Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: Analysis from a large-scale cohort

Medicine (United States)

Volumn 95, Issue 13, 2016, Pages e3164-

  Zhuang, Cheng Le ^a   Huang, Dong Dong ^a   Pang, Wen Yang ^a   Zhou, Chong Jun ^a   Wang, Su Lin ^a   Lou, Neng ^a   Ma, Liang Liang ^a   Yu, Zhen ^a,b   Shen, Xian ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GASTRECTOMY; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL GASTRECTOMY; RADICAL RESECTION; RETROSPECTIVE STUDY; SARCOPENIA; STOMACH CANCER; SURGICAL MORTALITY; ADVERSE EFFECTS; BODY COMPOSITION; CANCER STAGING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE; STOMACH NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84962777616     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003164     Document Type: Article

References (35)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108.
2. Kim Y, Ejaz A, Spolverato G, et al. Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative. Ann Surg Oncol. 2015;22:557-564.
3. Lepage C, Sant M, Verdecchia A, et al. Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br J Surg. 2010;97:235-239.
4. Wang W, Zheng C, Fang C, et al. Time trends of clinicopathologic features and surgical treatment for gastric cancer: results from 2 high-volume institutions in southern China. Surgery. 2015;158:1590-1597.
5. National Comprehensive Cancer Network. NCCN Guidelines for Treatment of Gastric Cancer. Version 3. 2015. Available at: http:// www.nccn.org/professionals/physician-gls/pdf/gastric.pdf [Assessed May 7, 2015].
6. Papenfuss WA, Kukar M, Oxenberg J, et al. Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol. 2014;21:3008-3014.
7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-423.
8. Wang SL, Zhuang CL, Huang DD, et al. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol. 2016;23:556-564.
9. Tegels JJ, van Vugt JL, Reisinger KW, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112:403-407.
10. Fukuda Y, Yamamoto K, Hirao M, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 20158.
11. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-123.
12. Japanese Gastric Cancer Association. Guidelines for diagnosis and treatment of carcinoma of the stomach. April 2004 edition. Available at: http:// www.jgca.jp/pdf/Guidelines2004-eng.pdf. [Accessed March 12, 2008].
13. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997-1006.
14. Lieffers JR, Bathe OF, Fassbender K, et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931-936.
15. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629-635.
16. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
17. Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol. 2015;22:4432-4437.
18. Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarci-noma. J Surg Oncol. 2015;111:771-775.
19. Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22:2663-2668.
20. Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short-and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 2015;261:1173-1183.
21. Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16:1478-1486.
22. Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261:345-352.
23. van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550-557.
24. Hayashi T, Yoshikawa T, Aoyama T, et al. Severity of complications after gastrectomy in elderly patients with gastric cancer. World J Surg. 2012;36:2139-2145.
25. Jiang N, Deng JY, Ding XW, et al. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol. 2014;20:8244-8252.
26. Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr. 2014;38:940-953.
27. Hall JC. Nutritional assessment of surgery patients. J Am Coll Surg. 2006;202:837-843.
28. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011;62:265-279.
29. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457-465.
30. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-159.
31. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115-122.
32. Phillips SM. Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr. 2015;6:452-460.
33. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489-495.
34. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539-1547.
35. Strong VE, Wu AW, Selby LV, et al. Differences in gastric cancer survival between the U.S. and China. J Surg Oncol. 2015;112:31-37.